Contemporary management of high-risk localized prostate cancer (Q37738788)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 2010

edit

Language	Label	Description	Also known as
English	Contemporary management of high-risk localized prostate cancer	scientific article published on May 2010

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20425622

retrieved

22 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Contemporary management of high-risk localized prostate cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20425622

retrieved

22 August 2017

main subject

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Mark Garzotto

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20425622

retrieved

22 August 2017

Arthur Y Hung

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20425622

retrieved

22 August 2017

publication date

1 May 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20425622

retrieved

22 August 2017

published in

Current urology reports

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20425622

retrieved

22 August 2017

volume

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20425622

retrieved

22 August 2017

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20425622

retrieved

22 August 2017

page(s)

159-164

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20425622

retrieved

22 August 2017

cites work

2008 Whitmore Lecture: Radical prostatectomy--where we were and where we are going

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11934-010-0101-0

retrieved

21 January 2018

[Image-guided radiotherapy by in-room CT-linear accelerator combination]

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11934-010-0101-0

retrieved

21 January 2018

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11934-010-0101-0

retrieved

21 January 2018

Preoperative neoadjuvant androgen withdrawal therapy in prostate cancer: the Canadian experience

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of pelvic lymphadenectomy for prostate cancer--therapeutic?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 2009

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer control with radical prostatectomy alone in 1,000 consecutive patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality results from a randomized prostate-cancer screening trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Duration of androgen suppression in the treatment of prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advances in imaging in the postoperative patient with a rising prostate-specific antigen level

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis of local recurrence after radical prostatectomy.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation Therapy Oncology Group 0521: A Phase III Randomized Trial of Androgen Suppression and Radiation Therapy Versus Androgen Suppression and Radiation Therapy Followed by Docetaxel/Prednisone for Localized, High-Risk Prostate Cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pelvic lymph node dissection in prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Veterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The 2010 NCCN clinical practice guidelines in oncology on prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of surgical approach (nerve bundle preservation versus wide local excision) on surgical margins and biochemical recurrence following radical prostatectomy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locally advanced prostate cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening and prostate-cancer mortality in a randomized European study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate specific antigen doubling time after radical prostatectomy: effect of neoadjuvant androgen deprivation therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

20-year outcomes following conservative management of clinically localized prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate cancer-associated gene expression alterations determined from needle biopsies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate specific antigen best practice statement: 2009 update.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20425622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11934-010-0101-0

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20425622

retrieved

22 August 2017

PubMed publication ID

20425622

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20425622

retrieved

22 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37738788&oldid=2200902876"